Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BoomRay and Novartis Pharma sign $900m deal for radioligand therapy
The partnership brings together BoomRay’s development experience in RLTs and Novartis’s global presence in the field. Credit: Michael Derrer Fuchs / Shutterstock.com.
The partnership brings together BoomRay’s development experience in RLTs and Novartis’s global presence in the field. Credit: Michael Derrer Fuchs / Shutterstock.com.